Association of Interleukin-6 With the Progression of Carotid Atherosclerosis-Reference-Cited by-同舟云学术

Association of Interleukin-6 With the Progression of Carotid Atherosclerosis

Published:2014-10 Issue:10 Volume:45 Page:2924-2929
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Okazaki Shuhei¹,Sakaguchi Manabu¹,Miwa Kaori¹,Furukado Shigetaka¹,Yamagami Hiroshi¹,Yagita Yoshiki¹,Mochizuki Hideki¹,Kitagawa Kazuo¹

Affiliation:

1. From the Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan (S.O., M.S., K.M., S.F., Y.Y., H.M.); Department of Neurology, National Cerebral and Cardiovascular Center, Osaka, Japan (H.Y.); and Department of Neurology, Tokyo Women’s Medical University, Tokyo, Japan (K.K.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference31 articles.

1. Inflammation at the Molecular Interface of Atherogenesis

2. How much is too much? Interleukin-6 and its signalling in atherosclerosis

3. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models

4. Novel anti-inflammatory strategies in atherosclerosis

5. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the therapeutic potential of interleukin-6 receptor blockade in cardiovascular disease treatment through Mendelian randomization;Scientific Reports;2024-09-13

2. Atherosclerosis and inflammation: Current therapeutic strategies. A review;Consilium Medicum;2024-05-02

3. Impacts of pro‐inflammatory cytokines variant on cardiometabolic profile and premature coronary artery disease: A systematic review and meta‐analysis;Journal of Cellular and Molecular Medicine;2024-04

4. An Evaluation of Plasma TNF, VEGF-A, and IL-6 Determination as a Risk Marker of Atherosclerotic Vascular Damage in Early-Onset CAD Patients;Journal of Clinical Medicine;2024-03-18

5. Dynamics of modified cardiovascular risk factors in patients with rheumatoid arthritis on the background of 5-year therapy with an interleukin 6 receptor inhibitor;Rheumatology Science and Practice;2024-03-01